Lawmakers welcome VA clearing red tape for advanced RNs
WASHINGTON – Sens. Jeff Merkley (D-OR) and Dick Durbin (D-IL), and Rep. Peter DeFazio (D-OR) welcomed news Wednesday that the Department of Veterans Affairs will implement one of the key proposals from the bipartisan Veterans Health Care Staffing Improvement Act, sponsored by Merkley and Sen. Mike Rounds (R-SD), helping to
Wyden, Merkley urge Trump: Don’t cut Medicare, Medicaid
A total of 21 Democrat U.S. senators, including Oregon’s Ron Wyden and Jeff Merkley, sent a letter Wednesday to President-elect Donald Trump to remind him of his campaign promises to reject cuts to Medicare and Medicaid and to ask that he clarify whether he still intends to do so. The
Sen. Jeff Merkley on Republicans’ efforts to repeal and delay
Sen. Jeff Merkley, the junior Democrat from Oregon, takes a dim view of his Republican colleagues’ strategy to immediately repeal the Affordable Care Act — but delay the effective date. Republicans don’t want the “the millions hurt by repeal to be hurt before the next election, so they push it beyond
Wyden, Merkley Announce $6 Million to Train Oregonians for Jobs in Growing Health Care Industry
Washington, D.C. – Today, Oregon Senators Ron Wyden and Jeff Merkley announced that the U.S. Department of Labor has awarded $6 million to help educate and train Oregonians for jobs in Oregon’s growing health care industry. The grant, awarded to Worksystems Inc., is part of America’s Promise, which helps cover education
Public Option for U.S. Health Insurance Gains Visibility in Debate Over Affordable Care Act
WASHINGTON—Advocates and opponents are gearing up for a life or death battle over a problematic Affordable Care Act in 2017, and the idea of a government option in health insurance is gaining some traction among Democratic legislators. Almost seven years ago, Congress and President Barack Obama undertook a health overhaul
Merkley Pushes for Stronger Generic Marketplace Following EpiPen Price Increase
Washington, DC—Oregon’s Senator Jeff Merkley today questioned a top official at the Food and Drug Administration (FDA) about the FDA’s role in the generic drug marketplace in light of the dramatic increase in the price of EpiPens this summer. At the hearing, Senator Merkley asked the FDA’s Director of the
English 
Spanish